Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer

PURPOSE: Although most breast cancer patients who receive neoadjuvant chemotherapy (NCT) have a tumor response, a small proportion experience progressive disease (PD). Predictors of response have been reported, but predictors for progression have not been identified. We sought to identify predictors...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Caudle, Abigail S., Gonzalez-Angulo, Ana M., Hunt, Kelly K., Liu, Ping, Pusztai, Lajos, Symmans, W. Fraser, Kuerer, Henry M., Mittendorf, Elizabeth A., Hortobagyi, Gabriel N., Meric-Bernstam, Funda
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2010
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860366/
https://ncbi.nlm.nih.gov/pubmed/20231683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.3286
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki